Success Metrics

Clinical Success Rate
95.0%

Based on 38 completed trials

Completion Rate
95%(38/40)
Active Trials
0(0%)
Results Posted
8%(3 trials)
Terminated
2(4%)

Phase Distribution

Ph phase_4
7
15%
Ph phase_3
10
22%
Ph phase_1
5
11%
Ph phase_2
9
20%
Ph not_applicable
15
33%

Phase Distribution

5

Early Stage

9

Mid Stage

17

Late Stage

Phase Distribution46 total trials
Phase 1Safety & dosage
5(10.9%)
Phase 2Efficacy & side effects
9(19.6%)
Phase 3Large-scale testing
10(21.7%)
Phase 4Post-market surveillance
7(15.2%)
N/ANon-phased studies
15(32.6%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

90.5%

38 of 42 finished

Non-Completion Rate

9.5%

4 ended early

Currently Active

0

trials recruiting

Total Trials

46

all time

Status Distribution
Completed(38)
Terminated(4)
Other(4)

Detailed Status

Completed38
unknown4
Terminated2
Withdrawn2

Development Timeline

Analytics

Development Status

Total Trials
46
Active
0
Success Rate
95.0%
Most Advanced
Phase 4

Trials by Phase

Phase 15 (10.9%)
Phase 29 (19.6%)
Phase 310 (21.7%)
Phase 47 (15.2%)
N/A15 (32.6%)

Trials by Status

terminated24%
unknown49%
completed3883%
withdrawn24%

Recent Activity

Clinical Trials (46)

Showing 20 of 46 trialsScroll for more
NCT02353702Phase 3

Efficacy of Local Anesthesic on Diaphragmatic Function After Upper Abdominal Surgery

Terminated
NCT06743009Not Applicable

Metabolic Effects of the Exercise-metabolite Lac-Phe

Completed
NCT04555291Not Applicable

Analgesic Effect of the QLB-3 for Patients Undergoing a Total Hip Surgery

Completed
NCT01259648Phase 4

Study Evaluating the Efficacy and Safety of Remifentanil in a Rapid Sequence Induction for Fragile Subjects

Completed
NCT06085963Not Applicable

Nasal Allergen Challenge Test as a Method to Detect Clinical Reactivity Against Birch Pollen

Completed
NCT03727971Phase 2

Treatment With the Anti-IgE Monoclonal Antibody Omalizumab in Women With Asthma Undergoing Fertility Treatment. - A Proof of Concept Study.

Completed
NCT06110494Phase 4

A New Clinical Use of Ferumoxytol Nanoparticles: An Antibiofilm Treatment

Completed
NCT04541979Phase 2

Aerosoliserat DNase for Treatment of Respiratory Failure in Severe COVID-19

Completed
NCT03788837Phase 3

ILOPROST in Septic Shock With Persistent Microperfusion Defects (I-MICRO)

Completed
NCT01843530Phase 3

Randomized, Double-blind, Two Arms, Multicenter, Phase III Study of Berinert for Treatment of ACE Induced Angioedema

Completed
NCT04793984Not Applicable

Efficacy and Safety Evaluation of Inhaleen Inhalation in Hospitalized COVID-19 Patients

Completed
NCT03640949Phase 2

Vasopressin and Methylprednisolone for In-Hospital Cardiac Arrest

Completed
NCT01823393Phase 4

Balloon Aortic Valvuloplasty Performed Without Heparin to Decrease Vascular and Bleeding Complications of the Procedure

Terminated
NCT02717494Phase 2

Safety and Immunogenicity of Anti-Pneumococcal Vaccines in HIV-Infected Pregnant Women

Completed
NCT01501760Phase 3

Efficacy and Safety Study of Avastin to Treat Neovascularisation of the Cornea

Completed
NCT04057755Phase 3

Botulinum Toxin A as a Treatment for Provoked Vestibulodynia

Completed
NCT02916355Not Applicable

Role of Interleukin (IL)-1 in Postprandial Fatigue - The Chäschüechli 2 Study

Completed
NCT01460537Phase 1

Phase 1 Study of PI3 (Phosphatidylinositol-3)-Kinase Inhibitor Copanlisib With Gemcitabine or Cisplatin Plus Gemcitabine in Patients With Advanced Cancer

Completed
NCT00696098Not Applicable

Effects of Butyrate on Colonic Health of Patients With Diarrhoea Predominant IBS and UC in Remission

Completed
NCT00693355Not Applicable

Effects of Butyrate Enemas on Colonic Health

Completed

Drug Details

Intervention Type
DRUG
Total Trials
46